CD44 and neoplasm: We further assessed whether ALK+ tumor cells expressing CD4 or CD8 also expressed CD44 or CD62L markers, usually used to distinguish naïve (CD62Lhigh CD44low), effector (CD62Llow CD44high) or central memory T cells (CD62Lhigh CD44high).